WallStreetZenWallStreetZen

NASDAQ: PTPI
Petros Pharmaceuticals Inc Stock

$0.65-0.02 (-2.99%)
Updated Apr 22, 2024
PTPI Price
$0.65
Fair Value Price
N/A
Market Cap
$4.47M
52 Week Low
$0.63
52 Week High
$6.35
P/E
-0.1x
P/B
0.37x
P/S
0.53x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.82M
Earnings
-$8.16M
Gross Margin
72%
Operating Margin
-131%
Profit Margin
-237.3%
Debt to Equity
1.77
Operating Cash Flow
-$8M
Beta
1.42
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PTPI Overview

Petros Pharmaceuticals, Inc. develops and commercializes therapeutics for men's health issues (erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, peyronie's disease, hormone health, and substance use disorders). lt markets its own line of ED products in the form of vacuum erection devices through its subsidiary, Timm Medical, Inc. Petros Pharmaceuticals was founded in 2020 and is headquartered in New York, NY.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PTPI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PTPI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PTPI is good value based on its book value relative to its share price (0.37x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.04x)
P/B vs Industry Valuation
PTPI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PTPI due diligence checks available for Premium users.

Be the first to know about important PTPI news, forecast changes, insider trades & much more!

PTPI News

Valuation

PTPI fair value

Fair Value of PTPI stock based on Discounted Cash Flow (DCF)
Price
$0.65
Fair Value
$3,984.53
Undervalued by
99.98%
PTPI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PTPI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.1x
Industry
46.47x
Market
41x

PTPI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.37x
Industry
2.04x
PTPI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PTPI's financial health

Profit margin

Revenue
-$364.3k
Net Income
$318.2k
Profit Margin
1,371%
PTPI's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
PTPI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$33.8M
Liabilities
$21.3M
Debt to equity
1.77
PTPI's short-term assets ($20.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PTPI's short-term assets ($20.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PTPI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PTPI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.3M
Investing
$0.0
Financing
-$2.4M
PTPI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PTPI vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
PTPI$4.47M-2.99%-0.10x0.37x
CPHI$4.70M-0.31%-0.35x0.63x
EVOK$3.86M-2.99%-0.20x-1.50x
YCBD$2.97M-2.50%-0.08x0.42x
SNOA$2.45M+4.67%-0.17x0.37x

Petros Pharmaceuticals Stock FAQ

What is Petros Pharmaceuticals's quote symbol?

(NASDAQ: PTPI) Petros Pharmaceuticals trades on the NASDAQ under the ticker symbol PTPI. Petros Pharmaceuticals stock quotes can also be displayed as NASDAQ: PTPI.

If you're new to stock investing, here's how to buy Petros Pharmaceuticals stock.

What is the 52 week high and low for Petros Pharmaceuticals (NASDAQ: PTPI)?

(NASDAQ: PTPI) Petros Pharmaceuticals's 52-week high was $6.35, and its 52-week low was $0.63. It is currently -89.76% from its 52-week high and 2.69% from its 52-week low.

How much is Petros Pharmaceuticals stock worth today?

(NASDAQ: PTPI) Petros Pharmaceuticals currently has 6,875,814 outstanding shares. With Petros Pharmaceuticals stock trading at $0.65 per share, the total value of Petros Pharmaceuticals stock (market capitalization) is $4.47M.

Petros Pharmaceuticals stock was originally listed at a price of $39.90 in Dec 2, 2020. If you had invested in Petros Pharmaceuticals stock at $39.90, your return over the last 3 years would have been -98.37%, for an annualized return of -74.65% (not including any dividends or dividend reinvestments).

How much is Petros Pharmaceuticals's stock price per share?

(NASDAQ: PTPI) Petros Pharmaceuticals stock price per share is $0.65 today (as of Apr 22, 2024).

What is Petros Pharmaceuticals's Market Cap?

(NASDAQ: PTPI) Petros Pharmaceuticals's market cap is $4.47M, as of Apr 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Petros Pharmaceuticals's market cap is calculated by multiplying PTPI's current stock price of $0.65 by PTPI's total outstanding shares of 6,875,814.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.